Clinical Trials in Phoenix

Showing 3361-3380 of 16,646 trials

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

NCT02675465

This is an international, multi-center, open-label study designed to evaluate if the co-administration of investigational new drugs ATB200 and AT2221 is safe in adults with Pompe disease.

Pompe Disease

Amicus Therapeutics29 participantsStarted Apr 2016

Phoenix, Arizona, United States • Orange, California, United States • Gainesville, Florida, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH

NCT04098250

This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence. The objective of the clinical trial component of the Focused Program is to determine whether intervention with erenumab is an effective treatment for PTH attributed to mTBI.

Post-Traumatic Headache

Mayo Clinic6 participantsStarted Jan 2021

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +2 more locations

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH

Find Trials by Condition in Phoenix

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

The Myelin Disorders Biorepository Project

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI